Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BDZVHG35
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) |
| Issuer | Blackrock |
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
| ETF Ticker | BTEE(USD) LSE |
| ETF Ticker | BTEE.L(GBP) LSE |
Holdings detail for GRFS
| Stock Name | Grifols SA ADR |
| Ticker | GRFS(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US3984384087 |
| LEI | 959800HSSNXWRKBK4N60 |
Show aggregate GRFS holdings
News associated with GRFS
- Analysts Set Grifols, S.A. (NASDAQ:GRFS) Price Target at $10.30
- Shares of Grifols, S.A. (NASDAQ:GRFS – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the five research firms that are presently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, one has assigned a buy recommendation and one has given a strong buy recommendation […] - 2025-09-12 02:01:00
- Ballentine Partners LLC Purchases Shares of 10,868 Grifols, S.A. (NASDAQ:GRFS)
- Ballentine Partners LLC acquired a new stake in Grifols, S.A. (NASDAQ:GRFS – Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 10,868 shares of the biotechnology company’s stock, valued at approximately $77,000. Several other institutional investors and hedge funds also recently […] - 2025-07-18 05:11:00
- Wall Street Zen Upgrades Grifols (NASDAQ:GRFS) to “Strong-Buy”
- Grifols (NASDAQ:GRFS – Get Free Report) was upgraded by Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report released on Monday. Separately, JPMorgan Chase & Co. lifted their target price on shares of Grifols from $7.60 to $10.30 and gave the company a “neutral” rating in a report on Tuesday, […] - 2025-07-09 02:10:51
- Analysts Anticipate KOMP To Hit $60
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-24 08:52:01
- JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Grifols (NASDAQ:GRFS) Stock
- Grifols (NASDAQ:GRFS – Get Free Report) had its target price lifted by equities researchers at JPMorgan Chase & Co. from $7.60 to $10.30 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the biotechnology company’s stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 18.39% […] - 2025-06-19 02:42:47
- Vident Advisory LLC Boosts Stock Holdings in Grifols, S.A. (NASDAQ:GRFS)
- Vident Advisory LLC raised its holdings in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) by 55.5% during the fourth quarter, HoldingsChannel reports. The firm owned 29,662 shares of the biotechnology company’s stock after purchasing an additional 10,590 shares during the period. Vident Advisory LLC’s holdings in Grifols were worth $221,000 as of its most […] - 2025-05-30 05:44:55
- 12,251 Shares in Grifols, S.A. (NASDAQ:GRFS) Acquired by Raymond James Financial Inc.
- Raymond James Financial Inc. acquired a new position in Grifols, S.A. (NASDAQ:GRFS – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 12,251 shares of the biotechnology company’s stock, valued at approximately $91,000. Several other institutional investors and hedge funds […] - 2025-05-14 04:22:48
- First Trust Advisors LP Invests $75,000 in Grifols, S.A. (NASDAQ:GRFS)
- First Trust Advisors LP purchased a new position in Grifols, S.A. (NASDAQ:GRFS – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 10,048 shares of the biotechnology company’s stock, valued at approximately $75,000. Other institutional investors also recently added to or […] - 2025-05-12 04:44:55
- The Implied Analyst 12-Month Target For KOMP
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-06 08:25:31
- Grifols, S.A. (NASDAQ:GRFS) Shares Purchased by Mariner LLC
- Mariner LLC increased its position in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) by 382.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 119,472 shares of the biotechnology company’s stock after purchasing an additional 94,706 shares during the period. Mariner […] - 2025-04-29 05:22:53
- Legal & General Group Plc Raises Holdings in Grifols, S.A. (NASDAQ:GRFS)
- Legal & General Group Plc lifted its stake in Grifols, S.A. (NASDAQ:GRFS – Free Report) by 159.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 329,953 shares of the biotechnology company’s stock after purchasing an additional 202,796 shares during the quarter. Legal & General […] - 2025-04-25 05:16:54
- Bank of Montreal Can Sells 6,039 Shares of Grifols, S.A. (NASDAQ:GRFS)
- Bank of Montreal Can cut its holdings in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) by 7.9% during the fourth quarter, Holdings Channel reports. The fund owned 70,856 shares of the biotechnology company’s stock after selling 6,039 shares during the quarter. Bank of Montreal Can’s holdings in Grifols were worth $527,000 as of its […] - 2025-04-22 04:52:58
- Grifols, S.A. (NASDAQ:GRFS) Shares Sold by Arrowstreet Capital Limited Partnership
- Arrowstreet Capital Limited Partnership cut its holdings in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) by 18.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 363,933 shares of the biotechnology company’s stock after selling 84,503 shares during the quarter. Arrowstreet […] - 2025-04-10 05:15:10
- KOMP's Underlying Holdings Could Mean 26% Gain Potential
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-26 08:51:12
- Grifols, S.A. (NASDAQ:GRFS) Shares Sold by Oppenheimer Asset Management Inc.
- Oppenheimer Asset Management Inc. lowered its holdings in Grifols, S.A. (NASDAQ:GRFS – Free Report) by 38.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 36,083 shares of the biotechnology company’s stock after selling 22,594 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in […] - 2025-03-07 06:45:05
- The Math Shows KOMP Can Go To $62
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-02-12 11:32:14
- R Squared Ltd Makes New $28,000 Investment in Grifols, S.A. (NASDAQ:GRFS)
- R Squared Ltd purchased a new position in Grifols, S.A. (NASDAQ:GRFS – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,760 shares of the biotechnology company’s stock, valued at approximately $28,000. Several other institutional investors and hedge […] - 2025-02-05 06:40:56
- China Universal Asset Management Co. Ltd. Raises Stock Position in Grifols, S.A. (NASDAQ:GRFS)
- China Universal Asset Management Co. Ltd. raised its stake in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) by 10.2% during the fourth quarter, Holdings Channel reports. The firm owned 25,867 shares of the biotechnology company’s stock after buying an additional 2,403 shares during the quarter. China Universal Asset Management Co. Ltd.’s holdings in Grifols […] - 2025-02-04 07:14:57
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) GRFS holdings
| Date | Number of GRFS Shares Held | Base Market Value of GRFS Shares | Local Market Value of GRFS Shares | Change in GRFS Shares Held | Change in GRFS Base Value | Current Price per GRFS Share Held | Previous Price per GRFS Share Held |
|---|
| 2025-11-11 (Tuesday) | 78,376 | USD 684,222 | USD 684,222 | 0 | USD 10,188 | USD 8.72999 | USD 8.60001 |
| 2025-11-10 (Monday) | 78,376 | USD 674,034 | USD 674,034 | 202 | USD 14,245 | USD 8.60001 | USD 8.44001 |
| 2025-11-07 (Friday) | 78,174 | USD 659,789 | USD 659,789 | 0 | USD 6,254 | USD 8.44001 | USD 8.36 |
| 2025-11-06 (Thursday) | 78,174 | USD 653,535 | USD 653,535 | 202 | USD -19,363 | USD 8.36 | USD 8.63 |
| 2025-11-05 (Wednesday) | 77,972 | USD 672,898 | USD 672,898 | 0 | USD -46,004 | USD 8.63 | USD 9.22 |
| 2025-11-04 (Tuesday) | 77,972 | USD 718,902 | USD 718,902 | 203 | USD -14,460 | USD 9.22 | USD 9.43 |
| 2025-11-03 (Monday) | 77,769 | USD 733,362 | USD 733,362 | 0 | USD 4,666 | USD 9.43 | USD 9.37001 |
| 2025-10-31 (Friday) | 77,769 | USD 728,696 | USD 728,696 | 0 | USD 16,332 | USD 9.37001 | USD 9.16 |
| 2025-10-30 (Thursday) | 77,769 | USD 712,364 | USD 712,364 | 1,015 | USD -8,356 | USD 9.16 | USD 9.39 |
| 2025-10-29 (Wednesday) | 76,754 | USD 720,720 | USD 720,720 | 406 | USD 6,103 | USD 9.39 | USD 9.36 |
| 2025-10-28 (Tuesday) | 76,348 | USD 714,617 | USD 714,617 | 0 | USD -1,527 | USD 9.36 | USD 9.38 |
| 2025-10-27 (Monday) | 76,348 | USD 716,144 | USD 716,144 | 0 | USD -6,108 | USD 9.38 | USD 9.46 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of GRFS by Blackrock for IE00BDZVHG35
Show aggregate share trades of GRFS| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-11-10 | BUY | 202 | 8.668 | 8.460 | 8.481 | USD 1,713 | 8.22 |
| 2025-11-06 | BUY | 202 | 8.635 | 8.210 | 8.253 | USD 1,667 | 8.21 |
| 2025-11-04 | BUY | 203 | 9.900 | 8.820 | 8.928 | USD 1,812 | 8.21 |
| 2025-10-30 | BUY | 1,015 | 9.400 | 9.140 | 9.166 | USD 9,303 | 8.19 |
| 2025-10-29 | BUY | 406 | 9.390 | 9.495 | 9.484 | USD 3,851 | 8.18 |
| 2025-10-22 | SELL | -808 | 9.550 | 9.610 | 9.604 | USD -7,760 | 8.14 Loss of -1,180 on sale |
| 2025-10-20 | BUY | 404 | 9.570 | 9.570 | 9.570 | USD 3,866 | 8.13 |
| 2025-10-17 | BUY | 1,009 | 9.650 | 9.730 | 9.722 | USD 9,809 | 8.12 |
| 2025-10-15 | BUY | 1,608 | 9.590 | 9.650 | 9.644 | USD 15,508 | 8.11 |
| 2025-10-03 | BUY | 1,421 | 9.950 | 10.160 | 10.139 | USD 14,408 | 8.09 |
| 2025-10-02 | BUY | 203 | 10.020 | 10.230 | 10.209 | USD 2,072 | 8.08 |
| 2025-09-30 | BUY | 406 | 9.960 | 10.080 | 10.068 | USD 4,088 | 8.06 |
| 2025-09-26 | BUY | 406 | 9.820 | 9.880 | 9.874 | USD 4,009 | 8.03 |
| 2025-09-25 | BUY | 406 | 9.760 | 9.810 | 9.805 | USD 3,981 | 8.02 |
| 2025-09-18 | BUY | 216 | 9.820 | 9.820 | 9.820 | USD 2,121 | 8.01 |
| 2025-09-17 | BUY | 651 | 9.750 | 9.890 | 9.876 | USD 6,429 | 8.00 |
| 2025-07-17 | SELL | -428 | 10.050 | 10.300 | 10.275 | USD -4,398 | 7.95 Loss of -995 on sale |
| 2025-07-16 | BUY | 2,851 | 10.090 | 10.220 | 10.207 | USD 29,100 | 7.94 |
| 2025-07-11 | SELL | -1,656 | 9.740 | 9.910 | 9.893 | USD -16,383 | 7.90 Loss of -3,300 on sale |
| 2025-07-02 | BUY | 11,385 | 9.140 | 9.180 | 9.176 | USD 104,469 | 7.86 |
| 2025-06-25 | BUY | 414 | 8.510 | 8.590 | 8.582 | USD 3,553 | 7.83 |
| 2025-06-11 | BUY | 416 | 8.950 | 9.080 | 9.067 | USD 3,772 | 7.76 |
| 2025-06-10 | BUY | 416 | 9.020 | 9.070 | 9.065 | USD 3,771 | 7.75 |
| 2025-06-04 | SELL | -208 | 8.450 | 8.690 | 8.666 | USD -1,803 | 7.72 Loss of -196 on sale |
| 2024-12-30 | SELL | -10,614 | 7.400 | 7.490 | 7.481 | USD -79,403 | 8.37 Profit of 9,478 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of GRFS
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 22,742 | 0 | 67,463 | 33.7% |
| 2025-09-18 | 26,477 | 0 | 87,441 | 30.3% |
| 2025-09-17 | 67,883 | 1,812 | 342,443 | 19.8% |
| 2025-09-16 | 44,844 | 1 | 301,400 | 14.9% |
| 2025-09-15 | 44,245 | 300 | 350,079 | 12.6% |
| 2025-09-12 | 27,812 | 0 | 111,490 | 24.9% |
| 2025-09-11 | 26,493 | 0 | 142,169 | 18.6% |
| 2025-09-10 | 35,480 | 900 | 218,110 | 16.3% |
| 2025-09-09 | 28,507 | 0 | 103,763 | 27.5% |
| 2025-09-08 | 16,834 | 0 | 115,308 | 14.6% |
| 2025-09-05 | 60,486 | 0 | 144,993 | 41.7% |
| 2025-09-04 | 31,954 | 0 | 195,660 | 16.3% |
| 2025-09-03 | 38,324 | 0 | 149,723 | 25.6% |
| 2025-09-02 | 31,615 | 0 | 149,732 | 21.1% |
| 2025-08-29 | 52,300 | 0 | 200,839 | 26.0% |
| 2025-08-28 | 40,588 | 0 | 249,637 | 16.3% |
| 2025-08-27 | 42,559 | 0 | 148,643 | 28.6% |
| 2025-08-26 | 32,934 | 0 | 158,843 | 20.7% |
| 2025-08-25 | 36,911 | 0 | 182,420 | 20.2% |
| 2025-08-22 | 105,099 | 0 | 401,966 | 26.1% |
| 2025-08-21 | 43,890 | 0 | 212,338 | 20.7% |
| 2025-08-20 | 72,511 | 0 | 259,735 | 27.9% |
| 2025-08-19 | 75,399 | 0 | 339,528 | 22.2% |
| 2025-08-18 | 69,300 | 0 | 252,087 | 27.5% |
| 2025-08-15 | 172,484 | 0 | 488,902 | 35.3% |
| 2025-08-14 | 414,526 | 0 | 2,926,277 | 14.2% |
| 2025-08-13 | 129,213 | 0 | 609,015 | 21.2% |
| 2025-08-12 | 133,752 | 0 | 380,141 | 35.2% |
| 2025-08-11 | 59,176 | 0 | 246,001 | 24.1% |
| 2025-08-08 | 35,012 | 0 | 237,413 | 14.7% |
| 2025-08-07 | 30,979 | 400 | 301,589 | 10.3% |
| 2025-08-06 | 93,767 | 0 | 751,951 | 12.5% |
| 2025-08-05 | 101,218 | 0 | 1,026,465 | 9.9% |
| 2025-08-04 | 50,249 | 0 | 190,605 | 26.4% |
| 2025-08-01 | 60,011 | 0 | 426,743 | 14.1% |
| 2025-07-31 | 44,239 | 0 | 269,580 | 16.4% |
| 2025-07-30 | 115,602 | 1,650 | 482,325 | 24.0% |
| 2025-07-29 | 277,523 | 1,200 | 2,031,038 | 13.7% |
| 2025-07-28 | 23,543 | 0 | 180,399 | 13.1% |
| 2025-07-25 | 53,263 | 0 | 218,429 | 24.4% |
| 2025-07-24 | 23,767 | 0 | 207,741 | 11.4% |
| 2025-07-23 | 59,082 | 3,084 | 275,115 | 21.5% |
| 2025-07-22 | 41,415 | 0 | 277,137 | 14.9% |
| 2025-07-21 | 27,823 | 0 | 1,098,974 | 2.5% |
| 2025-07-18 | 33,258 | 0 | 374,344 | 8.9% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.